|
Market Closed -
OTC Markets
09:31:37 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| Market Cap | 716K 618K 581K 529K 995K 67.95M 1M 6.87M 2.67M 34.56M 2.69M 2.63M 115M | P/E 2024 |
-0.6x | P/E 2025 | -0.38x |
|---|---|---|---|---|---|
| Enterprise Value | 12.04M 10.38M 9.77M 8.9M 16.73M 1.14B 16.82M 115M 44.95M 581M 45.2M 44.22M 1.93B | EV / Sales 2024 |
27.1x | EV / Sales 2025 | 31.2x |
| Free-Float |
98.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -50.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0 |
| 10 years | 0 | | 0.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Flax
CEO | Chief Executive Officer | 56 | 2001-10-31 |
Joe Lucas
COO | Chief Operating Officer | - | - |
| Chief Tech/Sci/R&D Officer | 64 | 2016-07-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Flax
BRD | Director/Board Member | 56 | 2001-10-31 |
Stewart Lonky
BRD | Director/Board Member | 78 | 2004-11-04 |
Garry Pottruck
BRD | Director/Board Member | 68 | 2009-07-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/15/21 | Buy | Executive/Senior Manager | 12,000,000 | - | ||
| 11/15/21 | Other | Executive/Senior Manager | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +9,900.00% | +9,900.00% | 716K | |
| +0.58% | +1.36% | -14.52% | -7.11% | 13.37B | |
| +0.50% | -0.99% | -33.45% | -56.57% | 4.87B | |
| 0.00% | -2.66% | -8.18% | -5.18% | 4.52B | |
| +0.69% | -0.31% | -4.12% | -30.38% | 3.96B | |
| +0.22% | +0.11% | -20.89% | +2.12% | 3.57B | |
| -1.08% | +2.65% | -0.54% | -2.29% | 3.55B | |
| +0.54% | +0.07% | -10.60% | +5.50% | 3.26B | |
| +0.87% | -1.70% | -24.37% | -13.70% | 2.34B | |
| +0.99% | +1.24% | -26.89% | -15.39% | 1.7B | |
| Average | +0.33% | +989.50% | +975.64% | +977.70% | 4.11B | |
| Weighted average by Cap. | +0.37% | -0.10% | -15.00% | -13.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 392K 338K 318K 290K 545K 37.22M 548K 3.76M 1.46M 18.93M 1.47M 1.44M 62.77M | 385K 332K 313K 285K 536K 36.57M 539K 3.7M 1.44M 18.6M 1.45M 1.42M 61.68M |
| Net income | -1.29M -1.11M -1.04M -950K -1.79M -122M -1.8M -12.33M -4.8M -62.07M -4.83M -4.72M -206M | -2.05M -1.77M -1.66M -1.51M -2.85M -194M -2.86M -19.64M -7.64M -98.84M -7.69M -7.52M -328M |
| Net Debt | 9.91M 8.55M 8.04M 7.32M 13.77M 940M 13.85M 95.05M 36.99M 478M 37.2M 36.39M 1.59B | 11.32M 9.77M 9.19M 8.37M 15.74M 1.07B 15.82M 109M 42.27M 547M 42.51M 41.59M 1.81B |
Employees
6
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$0.000100 | 0.00% | 400 |
| 26-08-28 | US$0.000100 | 0.00% | 9,000 |
- Stock Market
- Stocks
- NPHC Stock
Select your edition
All financial news and data tailored to specific country editions
